Abstract
The α-1L adrenoceptor (AR) was identified in rabbit ear artery by both functional and ligand binding studies. In functional studies using arterial rings, the contractile response to NS-49 [(R)-(-)-3′-(2-amino-1-hydroxyethyl)-4′-fluorometh-anesulfonanilide hydrochloride] (α-1A and α-1L AR-selective agonist) was competitively antagonized with low affinities by prazosin, RS-17053 [N-[2-(2-cyclopropylmethoxyphenoxy) ethyl]-5-chloro-α,α-dimethyl-1H-indole-3-ethamine hydrochloride], and 5-methylurapidil but with high affinities by tamsulosin and KMD-3213 [(-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2-[(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide]. In contrast, the response to noradrenaline (nonselective α-1 AR agonist) was inhibited noncompetitively by these antagonists (except 5-methylurapidil) with Schild slopes different from unity. These results suggest that the response to NS-49 was mediated predominantly via α-1L ARs, whereas the response to noradrenaline was produced through two distinct α-1 AR subtypes (presumably α-1B and α-1L ARs). In binding studies with intact segments of rabbit ear artery, [3H]KMD-3213 bound with high affinity (pKD = 9.7) to α-1 ARs, which were subdivided by prazosin, RS-17053, and 5-methylurapidil into two subtypes (α-1A and α-1L ARs). In contrast, [3H]prazosin binding sites in ear artery segments (pKD = 9.8) were identified as α-1A and α-1B ARs. In conventional binding studies using isolated rabbit ear artery microsomal membranes, [3H]KMD-3213 binding sites were identified as α-1A ARs with high affinities for prazosin, RS-17053, and 5-methylurapidil. Our study indicates that an α-1L AR having a unique pharmacological profile coexists with α-1A and α-1B ARs in rabbit ear artery and can be identified either functionally or by binding studies using intact tissues but not microsomal membrane preparations.
Footnotes
-
This study was supported in part by a Grant-in-Aid for Scientific Research and the 21st COE Research Program (Medical Science) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by a grant from the Smoking Research Foundation of Japan.
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.104.066985.
-
ABBREVIATIONS: AR, adrenoceptor; CL, confidence limit; KMD-3213, (-)-1-(3-hydroxypropyl)-5-[(2R)-2-({2-[(2,2,2-trifluoroethoxy)phenoxy] ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide; RS-17053, N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-α,α-dimethyl-1H-indole-3-ethamine hydrochloride; BMY 7378, (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4,5]decane-7,9-dione dihydrochloride; NS-49, (R)-(-)-3′-(2-amino-1-hydroxyethyl)-4′-fluoromethanesulfonanilide hydrochloride.
- Received February 13, 2004.
- Accepted April 20, 2004.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|